Gj. Sills et al., NEUROCHEMICAL STUDIES WITH THE NOVEL ANTICONVULSANT LEVETIRACETAM IN MOUSE-BRAIN, European journal of pharmacology, 325(1), 1997, pp. 35-40
Levetiracetam is a novel antiepileptic agent with a wide spectrum of a
ctivity against experimental and clinical seizures. The mechanism of i
ts anticonvulsant action remains to be determined. We have investigate
d the effects of levetiracetam on several gamma-aminobutyric acid (GAB
A)-related neurochemical parameters in mouse brain. Adult male mice we
re randomised into two groups and administered levetiracetam (0-300 mg
/kg) intraperitoneally either as a single dose or twice daily for 5 da
ys. Four hours after the final dose, animals were killed and their bra
ins removed. Brain tissues were analysed for concentrations of GABA, g
lutamate and glutamine and for the activities of GABA-transaminase and
glutamic acid decarboxylase. Single dose and repeated levetiracetam t
reatments were without effect on all of the parameters investigated. T
he anticonvulsant action of levetiracetam is unlikely to be mediated v
ia an action on the GABAergic system. (C) 1997 Elsevier Science B.V.